Company: HCWB
Filing Date: 2025-02-21
Form Type: DEF 14A
Source: 0001193125-25-032115
Chunk: 39

Company: HCW Biologics Inc.
Filing Date: 2025-02-21
Form: DEF 14A
Chunk 39
---
 by the DTC’s underwriting department, (c) the Transfer Agent is approved as an
agent in the DTC/FAST Program, (d) the Commitment Shares or Put Shares, as applicable, are otherwise eligible for delivery via DWAC, and (e) the Transfer Agent does not have a policy prohibiting or limiting delivery of the Put Shares or
Commitment Shares, as applicable, via DWAC.

“” means shares of Common Stock that are (i) issued in
electronic form, (ii) freely tradable and transferable and without restriction on resale and (iii) timely credited by the Company to the Investor’s or its designee’s specified DWAC account with DTC under the DTC/FAST Program, or
any similar program hereafter adopted by DTC performing substantially the same function.

“” means the
Principal Market or any nationally recognized exchange upon which the Common Stock is listed.

“” shall
have the meaning set forth in .

“” shall mean the Securities Exchange
Act of 1934, as amended, and the rules and regulations promulgated thereunder.

“” shall have the meaning
set forth in the preamble to this Agreement.

“” shall mean the Financial Industry Regulatory Authority, Inc.

“” shall have the meaning specified in .

“” shall have the meaning specified in .

“” shall have the meaning specified in .

“” shall mean all trademarks, trademark applications, trade names, service marks, service mark
registrations, service names, patents, patent applications, patent rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other intellectual property rights.

“” shall mean the dollar value equal to the amount of Put Shares referenced in the Put Notice multiplied by
the Purchase Price minus the Clearing Costs.

“” shall have the meaning specified in the preamble to this
Agreement.

“” shall have the meaning specified in .

“” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right, or any other
restriction.

“” shall mean any effect on the business, operations, properties, or financial
condition of the Company and/or the Subsidiaries that is material and adverse to the Company and/or the

- A-3 -

Subsidiaries and/or any condition, circumstance, or situation that would prohibit or otherwise materially interfere with the ability of the Company and/or the Subsidiaries to enter into and/or
perform its obligations under